Tag: drug discovery
OpenAI Foundation puts $40M behind cancer vaccine data collection
The nonprofit parent of OpenAI is funding dataset creation it says medical AI needs before models can deliver new cures.
10x Genomics adopts Lunit’s H&E AI for biomarker discovery
The Seoul-based imaging AI developer will supply tissue analysis for 10x's spatial biology oncology research programs.
Ono taps Aitia’s causal AI twins to unmask neurology drug targets
Ono Pharma will use Aitia's causal AI digital twins to find new drug targets in neurological disease.
Drugmaker turns to ChatGPT and Gemini to revive renin inhibitors
Sheo Pharmaceuticals used the chatbots to study past failures, then built its own models to design a candidate.
Flagship’s ProFound nets $35M to hunt preeclampsia targets
Flagship's ProFound Therapeutics gets up to $35M from the Gates Foundation to hunt new preeclampsia drug targets.
KAIST’s K-Fold model predicts drug-protein binding 25x faster
KAIST's homegrown K-Fold model predicts protein-drug binding structures up to 25 times faster than existing AI.
Nine repurposed drugs show neuron protection in Sanfilippo model
A Nature Communications study pairs drug screening with machine learning against MPS IIIA.
GenBio launches stateful AIDO Cell to simulate whole human cells
GenBio AI launches AIDO Cell, a stateful virtual cell that predicts how DNA, RNA and proteins shape whole-cell behavior.